Flagship-backed companies stake out space in Somerville’s first lab building

A rendering of the future nine-story lab at 101 South St. in Somerville, the first phase of the 1.3 million-square-foot Boynton Yards development.

Life-science companies backed by Cambridge’s Flagship Pioneering are leasing a combined 208,000 square feet at Somerville's Boynton Yards, the city's first lab building.

Tessera Therapeutics, Cellarity and Laronde will move to 101 South St. this fall. Flagship has an option to expand into the balance of the building, as well as a second option for a 300,000-square-foot building that will be built by late 2023.

The Business Journal first reported earlier this month that Flagship was in advanced discussions to lease space for several of its companies at 101 South St.

“Flagship’s expansion into Somerville gives a number of our companies the space they need for their critical growth trajectories while remaining close to Flagship’s wider ecosystem of 40-plus companies within Cambridge,” said Christine Heenan, senior partner at Flagship Pioneering, in a statement. “Flagship is excited to be one of the first entrants into this emerging community for life science companies in Somerville. We are excited about what the future will hold there, for Flagship and for Somerville.”

Read the full article at The Boston Business Journal →